David Oron
InvestorAnalyst at HEALTHCARE ROYALTY PARTNERS
About
David Oron is an Analyst at HCRx, where he supports transaction-related work including financial analysis, transaction structuring, due diligence, and business development. He previously worked as a strategy consultant at Putnam, advising biopharma clients on commercial and access strategy. He holds a BS in Biomedical Engineering from Cornell University.
Invests in
Biotech
Colleagues at HEALTHCARE ROYALTY PARTNERS
Aaron B. Simon
Associate at HEALTHCARE ROYALTY PARTNERS
Amy J. Zacharias
Senior Vice President and Controller at HEALTHCARE ROYALTY PARTNERS
Andrew Logerfo
Vice President at HEALTHCARE ROYALTY PARTNERS
Carlos M. Almodóvar
Chief Business Officer at HEALTHCARE ROYALTY PARTNERS
Christopher A. White
President and Chief Financial Officer at HEALTHCARE ROYALTY PARTNERS
Clarke B. Futch
Chairman and Chief Executive Officer at HEALTHCARE ROYALTY PARTNERS
Eric Yoo
Vice President, PharmD at HEALTHCARE ROYALTY PARTNERS
Evan Bograd
Vice President at HEALTHCARE ROYALTY PARTNERS
Frequently asked questions
- Who is David Oron?
- David Oron is an Analyst at HCRx, where he supports transaction-related work including financial analysis, transaction structuring, due diligence, and business development. He previously worked as a strategy consultant at Putnam, advising biopharma clients on commercial and access strategy. He holds a BS in Biomedical Engineering from Cornell University.
- Where does David Oron work?
- David Oron is Analyst at HEALTHCARE ROYALTY PARTNERS.
- What does David Oron invest in?
- David Oron invests in Biotech.